Prevalence and Spectrum of Congenital Heart Disease in Individuals With Distal Chromosome 22q11.22–23 Deletions
This study is aimed at determining the spectrum of congenital heart disease associated with distal 22q11.22-23 deletions flanked by low copy repeats, LCR22 D-H. We analyzed cardiology findings in 128 unrelated individuals with distal LCR22 D-H deletions. A total of 62 were newly described and 66 were derived from previous reports. We found that deletions which included LCR22-D as the proximal endpoint were the most prevalent in the cohort (104/128, 81.3%). Clinically relevant congenital heart disease was identified in 48 individuals (37.5%, 95% CI 29%-46%), which is lower than the prevalence reported for typical, proximal LCR22 A-D deletions (p = 3.7E-4), especially for conotruncal defects (13/128, 10.2%; p = 7.1E-13). Mild to moderate CHD predominated, including ventricular septal defects (22/128), bicuspid aortic valve (9/128) and mild cardiomyopathy (3/128). Persistent truncus arteriosus was the most prevalent (n = 8/13) conotruncal heart defect, but other anomalies also occurred in singleton cases. These findings support the need for cardiac evaluation in all individuals with distal 22q11.22-23 deletions, increased use of clinical genetic testing in syndromic individuals with these findings, and molecular studies in model systems. The results demonstrate that reduced gene dosage of distal 22q11.21-23, particularly within the D-E region including MAPK1 and HIC2 convey risk for CHD.
Authors
- Oanh Tran (ORCID: https://orcid.org/0009-0006-4624-8142)
- Bruno Marino (ORCID: https://orcid.org/0000-0002-9256-5556)
- M. Cristina Digilio (ORCID: https://orcid.org/0000-0002-9168-3606)
- Elaine H. Zackai (ORCID: https://orcid.org/0000-0002-8002-893X)
- Marta Unolt (ORCID: https://orcid.org/0000-0002-4133-714X)
- Audrey Green
- Jeroen Breckpot (ORCID: https://orcid.org/0000-0002-0734-5154)
- Thomas A. Nelson
- Beverly S. Emanuel (ORCID: https://orcid.org/0000-0002-9207-6955)
- Elizabeth Goldmuntz (ORCID: https://orcid.org/0000-0003-2936-4396)
- Bernice E. Morrow (ORCID: https://orcid.org/0000-0002-8076-4726)
- Federica Pulvirenti (ORCID: https://orcid.org/0000-0002-3466-9496)
- Donna M. McDonald‐McGinn (ORCID: https://orcid.org/0000-0003-4077-250X)
- Daniella Miller (ORCID: https://orcid.org/0000-0002-5889-9739)
- Erik Boot (ORCID: https://orcid.org/0000-0002-0593-1539)
- Carolina Putotto (ORCID: https://orcid.org/0000-0003-3778-3769)
- Daniel E. McGinn (ORCID: https://orcid.org/0009-0008-6006-1426)
- Zhengdong D. Zhang (ORCID: https://orcid.org/0000-0001-9508-1429)
- Terrence Blaine Crowley (ORCID: https://orcid.org/0000-0002-3272-5458)
- Ann Swillen (ORCID: https://orcid.org/0000-0003-4258-4537)
- Victoria Giunta (ORCID: https://orcid.org/0009-0007-0796-2439)
- Anne S. Bassett (ORCID: https://orcid.org/0000-0002-0681-7279)
- Lydia Rockart
Institutions
- Albert Einstein College of Medicine (US)
- University Health Network (CA)
- Children's Hospital of Philadelphia (US)
- Centre for Addiction and Mental Health (CA)
- University of Toronto (CA)
- Toronto General Hospital (CA)
- Maastricht University (NL)
- Center for Human Genetics (US)
- Bambino Gesù Children's Hospital (IT)
- 's Heeren Loo (NL)
- University of Pennsylvania (US)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Clinical Genetics
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1111/cge.70118
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Children's Hospital of Philadelphia
- University of Toronto
- Sapienza Università di Roma
- National Institutes of Health
- Canadian Institutes of Health Research